230 related articles for article (PubMed ID: 12689926)
21. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
22. Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype.
Dianzani U; Omedè P; Marmont F; DiFranco D; Fusaro A; Bragardo M; Redoglia V; Giaretta F; Mairone L; Boccadoro M
Blood; 1994 Apr; 83(8):2198-205. PubMed ID: 7909242
[TBL] [Abstract][Full Text] [Related]
23. Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4 perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype.
Walton JA; Lydyard PM; Nathwani A; Emery V; Akbar A; Glennie MJ; Porakishvili N
Br J Haematol; 2010 Jan; 148(2):274-84. PubMed ID: 19895614
[TBL] [Abstract][Full Text] [Related]
24. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia.
Lundin J; Porwit-MacDonald A; Rossmann ED; Karlsson C; Edman P; Rezvany MR; Kimby E; Osterborg A; Mellstedt H
Leukemia; 2004 Mar; 18(3):484-90. PubMed ID: 14749699
[TBL] [Abstract][Full Text] [Related]
26. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.
Riches JC; Davies JK; McClanahan F; Fatah R; Iqbal S; Agrawal S; Ramsay AG; Gribben JG
Blood; 2013 Feb; 121(9):1612-21. PubMed ID: 23247726
[TBL] [Abstract][Full Text] [Related]
27. Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes.
Mous R; Savage P; Remmerswaal EB; van Lier RA; Eldering E; van Oers MH
Leukemia; 2006 Jun; 20(6):1096-102. PubMed ID: 16557240
[TBL] [Abstract][Full Text] [Related]
28. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314
[TBL] [Abstract][Full Text] [Related]
29. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
30. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process.
Libri V; Azevedo RI; Jackson SE; Di Mitri D; Lachmann R; Fuhrmann S; Vukmanovic-Stejic M; Yong K; Battistini L; Kern F; Soares MV; Akbar AN
Immunology; 2011 Mar; 132(3):326-39. PubMed ID: 21214539
[TBL] [Abstract][Full Text] [Related]
32. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.
Martinez A; Pittaluga S; Villamor N; Colomer D; Rozman M; Raffeld M; Montserrat E; Campo E; Jaffe ES
Am J Surg Pathol; 2004 Jul; 28(7):849-58. PubMed ID: 15223953
[TBL] [Abstract][Full Text] [Related]
33. Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8 T cells as compared with EBV-reactive CD8 T cells.
Sauce D; Rufer N; Mercier P; Bodinier M; Rémy-Martin JP; Duperrier A; Ferrand C; Hervé P; Romero P; Lang F; Tiberghien P; Robinet E
Blood; 2003 Aug; 102(4):1241-8. PubMed ID: 12730101
[TBL] [Abstract][Full Text] [Related]
34. Quantification and phenotypic characterization of peripheral blood Vδ1 + T cells in chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Simões C; Silva I; Carvalho A; Silva S; Santos S; Marques G; Ribeiro A; Roque A; Carda J; Sarmento-Ribeiro AB; Domingues MDR; Ribeiro L; Paiva A
Cytometry B Clin Cytom; 2019 Mar; 96(2):164-168. PubMed ID: 30334339
[TBL] [Abstract][Full Text] [Related]
35. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
Jagannathan P; Osborne CM; Royce C; Manion MM; Tilton JC; Li L; Fischer S; Hallahan CW; Metcalf JA; McLaughlin M; Pipeling M; McDyer JF; Manley TJ; Meier JL; Altman JD; Hertel L; Davey RT; Connors M; Migueles SA
J Virol; 2009 Mar; 83(6):2728-42. PubMed ID: 19129459
[TBL] [Abstract][Full Text] [Related]
36. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.
Zhang D; Shankar P; Xu Z; Harnisch B; Chen G; Lange C; Lee SJ; Valdez H; Lederman MM; Lieberman J
Blood; 2003 Jan; 101(1):226-35. PubMed ID: 12393740
[TBL] [Abstract][Full Text] [Related]
37. Hanging tough: CMV-specific CD8+ T cells in CLL.
Riches JC; Gribben JG
Blood; 2014 Jan; 123(5):608-9. PubMed ID: 24482498
[TBL] [Abstract][Full Text] [Related]
38. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
[TBL] [Abstract][Full Text] [Related]
39. Expanded antigen-experienced CD160
Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
[TBL] [Abstract][Full Text] [Related]
40. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
